Comparing pill combinations for cholesterol after a heart attack
Part of Heart & circulation clinical trials.
This study tests whether adding a medication called bempedoic acid to standard cholesterol-lowering pills is better at lowering cholesterol after a heart attack. If you have recently had a heart attack and are already on statins, this might be an option to help prevent future heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You were recently in the hospital for a heart attack or related chest pain.
- Your LDL ('bad') cholesterol is between 70 and 140 mg/dL when tested in the hospital.
- You are already taking a statin, with or without ezetimibe, at the time you leave the hospital.
- You are not currently taking a stronger type of cholesterol drug called PCSK9 inhibitors or inclisiran.
- You do not have certain severe health conditions, including kidney or liver problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding an extra cholesterol-lowering drug (bempedoic acid) to the usual treatment soon after a heart attack or related event can lower 'bad' cholesterol more effectively. It may help reduce the risk of future heart problems.
This study compares two approaches to lowering 'bad' cholesterol (LDL-C) in people hospitalized with acute coronary syndrome (a heart attack or unstable angina). One approach uses two medications (a statin plus another pill), and the other uses three (adding an injectable medicine). The goal is to see if the triple therapy lowers cholesterol more effectively and helps prevent future heart problems.
This study tests whether adding bempedoic acid (a cholesterol-lowering pill) to standard care after a heart attack helps recovery and reduces inflammation. It may help lower your risk of future heart problems.
This trial tests a triple combination of medications (bempedoic acid, ezetimibe, and a high-intensity statin) in people who have never had a heart attack or stroke but have moderate to severe coronary artery disease. The goal is to see if this combination lowers cholesterol and reduces future heart risks more effectively than standard care.
This study compares a newer cholesterol-lowering medicine called bempedoic acid to statins in people who have trouble sticking with statins. It aims to see which treatment lowers LDL cholesterol more effectively and is easier to tolerate.
This study observes patients with high cholesterol or mixed lipid disorders who are taking bempedoic acid, alone or with ezetimibe, to see how it works in real life. It aims to gather information that may help doctors better manage cholesterol.
Hear when a new Secondary Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.